Government Approves FDI Proposals of Wockhardt, Aurobindo Pharma

Published On 2016-05-19 07:17 GMT   |   Update On 2016-05-19 07:17 GMT

New Delhi : The Foreign Investment Promotion Board (FIPB) has approved Rs.60.73 crore worth of foreign direct investment (FDI) proposals of Wockhardt, Aurobindo Pharma and Advanced Enzyme Technologies.


"The government has approved three proposals of FDI amounting to Rs.60.73 crore approximately," the finance ministry said in a statement here on Wednesday.


The decision was taken at a FIPB meet held on April 29, the statement said.


The FIPB has also recommended to the Cabinet Committee on Economic Affairs (CCEA) for approval the Axis Bank proposal to increase the foreign investment limit in the bank to 74 percent from the current 62 percent, the statement said.


The Axis Bank's proposal involves FDI of Rs.12,973.14 crore, it said.

Article Source : IANS

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News